Transplant Diagnostics Market in United Kingdom, United States

1. Executive Summary: Transplant Diagnostics
   • Global Market Outlook: Transplant Diagnostics
2. Competitive Intelligence Analysis: Transplant Diagnostics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Transplant Diagnostics
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Transplant Diagnostics
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Transplant Diagnostics: Ten Major Market (10MM) – Market Analysis, By Technology
   • Molecular Assay
     • PCR-based Molecular Assay
     • Sequencing-based Molecular Assay
   • Non-molecular Assay
     • Serological Assay
     • Mixed Lymphocyte Culture Assay

9. Transplant Diagnostics: Ten Major Market (10MM) – Market Analysis, By Product
   • Reagents & Consumables
   • Instruments
   • Software and Services
10. Transplant Diagnostics: Ten Major Market (10MM) – Market Analysis, By Application
    • Diagnostics (Donor and Recipient Testing)
    • Translational Research
11. Transplant Diagnostics: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

12. S. Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

13. K. Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

14. Germany Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

15. France Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

16. Italy Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

17. Spain Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

18. Japan Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

19. China Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

20. Australia Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

21. India Transplant Diagnostics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Product
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Product
      • By Application

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer

Transplant Diagnostics Market – Report Overview

Pacific Business Consulting’s “Transplant Diagnostics Market in United Kingdom – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Transplant Diagnostics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Transplant Diagnostics market in United States exceeded a valuation of over US$ 4.5 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 10.0% from 2023 to 2030. The market is expected to potentially surpass US$ 9.5 Billion by 2030.

Transplantation stands as a preferred treatment for patients grappling with end-stage renal disease undergoing chronic dialysis therapy, extending to viable options for heart, liver, and bone marrow cases. Over the past decade, significant improvements in diagnostics have emerged, marked by companies’ commitment to enhancing HLA typing technologies, antibody monitoring, instruments, and software. These advancements are gradually finding applications in diagnosing transplantation procedures for various organs in the body.

Organ transplant diagnosis in Australia is a diagnostic procedure involving various tests conducted before the relocation or transplantation of a donor organ to the recipient patient. This essential process assesses various aspects associated with the transplant both pre- and post-transplantation. Organ transplant diagnostics play a crucial role in ensuring histocompatibility between the donor and recipient organs, minimizing the risk of rejection, and diagnosing potential occurrences of infections or disorders. These diagnostic measures are instrumental in safeguarding the overall success and well-being of organ transplant recipients.

The upswing in organ donations plays a pivotal role in propelling market growth. Data from the Association of Organ Procurement Organizations (AOPO) revealed that in 2020, over 12,500 individuals donated one or more organs, marking a 6% increase from the preceding year. Organs donated from deceased donors surpassed 36,500, reflecting an almost 2% year-over-year increase. Over the past seven years, organs from deceased donors saved more than 33,000 lives, surpassing previous year totals. Notably, donations after circulatory death (DCD) exceeded 3,000 donors in 2020. This surge in organ donations underscores the need for enhanced transplant diagnostic testing, thereby fueling market growth. Initiatives by the European Commission and the availability of the European donor card have contributed to increased organ donation rates in the region, while the U.S. has seen substantial growth in organ donations due to heightened awareness.

Strategic partnerships and product launches by market players further contribute to market expansion in Japan. For example, bioMérieux S.A. and Oxford Nanopore entered a partnership in April 2023 to develop innovative infectious disease diagnostics for transplantation use. Thermo Fisher Scientific expanded its transplant diagnostics portfolio with two new products in September 2021. CareDx and Miromatrix announced an exclusive partnership in April 2023 to advance research on bioengineered organs for human transplantation. GenDx partnered with Azure Biosystems in December 2022 to demonstrate compatibility between the Azure Cielo 6 qPCR System and GenDx KMRtype and KMRtrack kits. Bio-Rad Laboratories and NuProbe USA signed a licensing agreement for digital PCR assay development in November 2022. Eurobio Scientific acquired a 100% stake in Genome Diagnostics BV (GenDx) in October 2022 in a deal valued at $132.3 million.

Factors driving market growth include the increased adoption of stem cell therapy, a surge in leukemia cases, and the demand for advanced molecular and genomic technologies in transplant diagnostics. A favorable regulatory scenario, including reimbursement schemes, also supports market expansion.

However, challenges exist, such as a widening gap between organ donation and transplant demand, hindering the growth of the organ transplant diagnostics market in France. The high cost of investment for transplant diagnostics tests poses another obstacle to market development.

Leading players in the Transplant Diagnostics segment, including Abbott Laboratories, Biomérieux SA, Qiagen NV, Thermo Fisher Scientific Inc., F Hoffmann La Roche AG, Bio-Rad Laboratories, Inc., BAG Group GmbH, Eurobio Scientific (Genome Diagnostics B.V.), Illumina, Inc., and Immucor, Inc., are expected to play a crucial role in shaping the future landscape of Transplant Diagnostics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Transplant Diagnostics market. It also delves into the analysis of present and prospective market competition within the global Transplant Diagnostics market in China.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Transplant Diagnostics market in Germany across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the Transplant Diagnostics market in Italy.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.